Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC

Condition:   Head and Neck Squamous Cell Carcinoma
Interventions:   Drug: Cisplatin;   Drug: 5-Fluorouracile;   Drug: Docetaxel;   Drug: Cetuximab;   Drug: granulocyte colony-stimulating factor (G-CSF)
Sponsors:   Groupe Oncologie Radiotherapie Tete et Cou;   Grupo Español de Tratamiento de Tumores de Cabeza y Cuello;   AIO-Studien-gGmbH
Recruiting - verified February 2017

http://ift.tt/2l7qIW6